Skip to main content
SpringerLink
Log in
Book cover

Tumor Prevention and Genetics pp 226–231Cite as

Problems with Prostate-Specific Antigen Screening: A Critical Review

  • Conference paper

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 163))

Abstract

The effect of population screening with regard to reduction of prostate cancer specific mortality and quality of life issues is not yet clear. Several national and international prospective studies are currently being conducted to answer these important questions. They include the trials in the Federal State of Tyrol, Austria and in the Quebec City area, Canada, as well as the Prostate, Lung, Colorectal and Ovarian (PLCO) trial in the United States and the European Randomized Study of Screening for Prostate Cancer (ERSPC). In the meantime, individual case finding (opportunistic screening) is recommended for men with a life-expectancy of at least 10 years.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Abbreviations

PSA:

prostate-specific antigen

EGTM:

European Group on Tumor Markers

DRE:

digital rectal examination

PLCO:

Prostate, Lung, Colorectal and Ovarian Cancer Screening Project

ERSPC:

European Randomized Study of Screening for Prostate Cancer

References

  • Aus G, Abbou CC, Pacik D, Schmid H-P, van Poppel H, Wolff JM, Zattoni F (2001) EAU guidelines on prostate cancer. Eur UroI 40:97–101

    Article  CAS  Google Scholar 

  • Bartsch G, Horninger W, Klocker H, Reissigl A, Oberaiger W, Schonitzer D, Severi G, Robertson C, Boyle P (2001) Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the federal state of Tyrol, Austria. Urology 58: 417–424

    Article  PubMed  CAS  Google Scholar 

  • Fossa SD, Eri LM, Skovlund E, Tveter K, Vatten L, for the Norwegian Urological Cancer Group (2001) No randomised trial of prostate-cancer screening in Norway. Lancet Oncol 2:741–745

    Article  PubMed  CAS  Google Scholar 

  • Gohagan JK, Prorok PC, Kramer BS, Cornett JE (1994) Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. J UroI 152:1905–1909

    CAS  Google Scholar 

  • Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer stat istics, 2001. CA Cancer J Clin 51:15–36

    Article  PubMed  CAS  Google Scholar 

  • Labrie F, Candas B, Dupont A, Cusan L, Gomez J-L, Suburu RE, Diamond P, Levesque J, Belanger A (1999) Screening decreas es prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial. Prostate 38:83–91

    Article  PubMed  CAS  Google Scholar 

  • Legler JM, Feuer EJ, Potosky AL, Merrill RM, Kramer BS (1998) The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States. Cancer Causes Control 9:519–527

    Article  PubMed  CAS  Google Scholar 

  • Madalinska JB, Essink-Bot ML, de Koning HJ, Kirkels WJ, van der Maas PJ, Schroder FH (2001) Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol 19:1619–1628

    PubMed  CAS  Google Scholar 

  • Schröder FH, Roobol-Bouts M, Vis AN, van der Kwast T, Kranse R (2001) Prostate-specific antigen-based early detection of prostate cancer validation of screening without rectal examination. Urology 57:83–90

    Article  PubMed  Google Scholar 

  • Semjonow A, Schmid H-P (2002) The rise and fall of PSA: clinical implications of prostate specific antigen kinetics. Urol Res 30:85–88

    Article  PubMed  CAS  Google Scholar 

  • Semjonow A, Albrecht W, Bialk P, Gerl A, Lamerz R, Schmid H-P, Van Poppel H (1999) Tumour markers in prostate cancer: EGTM recommendations. Antican cer Res 19:2799–2801

    Google Scholar 

  • Stamey TA, Freiha FS, McNeal IE, Redwine EA, Whittemore AS, Schmid H-P (1993) Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71:933–938

    Article  PubMed  CAS  Google Scholar 

  • Vutuc C, Waldhoer T, Madersbacher S, Micksche M, Haidinger G (2001) Prostate cancer in Austria: impact of prostate-specific antigen test on incidence and mortality. Eur J Cancer Prev 10:425–428

    Article  PubMed  CAS  Google Scholar 

  • Wilson JMG, Jungner G (1969) Principles and practice of screening for disease. Public Health Paper No. 34, World Health Organization, Geneva, Switzerland

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Kantonsspital, 9007, St. Gallen, Switzerland

    Hans-Peter Schmid, Ladislav Prikler & Axel Semjonow

Authors
  1. Hans-Peter Schmid
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ladislav Prikler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Axel Semjonow
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentrum für Tumordiagnostik und Prävention, Rorschacherstr. 150, 9006, St. Gallen, Switzerland

    Hans-Jörg Senn  & Rudolf Morant  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schmid, HP., Prikler, L., Semjonow, A. (2003). Problems with Prostate-Specific Antigen Screening: A Critical Review. In: Senn, HJ., Morant, R. (eds) Tumor Prevention and Genetics. Recent Results in Cancer Research, vol 163. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55647-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55647-0_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62892-4

  • Online ISBN: 978-3-642-55647-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation